Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions

Brain Research

Volumn 767, Issue 1, 1997, Pages 8-16

  Ragnauth, Andre ^a   Ruegg, Hildegard ^a   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

1 Opioid receptor; 2 Opioid receptor; Opioid receptor; Opioid receptor; Food deprivation; Glucoprivic intake; Palatability; Ventral tegmental area

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NORBINALTORPHIMINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOOD DEPRIVATION; FOOD INTAKE; GLUCOSE INTAKE; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PALATABILITY; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; VENTRAL TEGMENTUM;

DEOXYGLUCOSE; EATING; ENKEPHALIN, LEUCINE-2-ALANINE; EVALUATION STUDIES; FOOD DEPRIVATION; HYPERPHAGIA; INSULIN; NALTREXONE; NARCOTIC ANTAGONISTS; SUCROSE; VENTRAL TEGMENTAL AREA;

EID: 0030826279     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00539-8     Document Type: Article

References (77)

1. Arjune D., Bodnar R.J. Suppression of nocturnal, palatable and glucoprivic intake in rats by the κ opioid antagonist, nor-binaltorphamine. Brain Res. 534:1990;313-316.
2. 6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the δ opioid receptor. Pharmacol. Biochem. Behav. 39:1991;429-436.
3. Arjune D., Standifer K.M., Pasternak G.W., Bodnar R.J. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535:1990;101-109.
4. Badiani A., Leone P., Noel M.B., Stewart J. Ventral tegmental area opioid mechanisms and modulation of ingestive behavior. Brain Res. 670:1995;264-276.
5. Badiani A., Leone P., Stewart J. Intra-VTA injections of the μ-opioid antagonist CTOP enhance locomotor activity. Brain Res. 690:1995;112-116.
6. Beczkowska I.W., Bodnar R.J. Mediation of insulin hyperphagia by specific central opiate receptor antagonists. Brain Res. 547:1991;315-318.
7. Beczkowska I.W., Bowen W.D., Bodnar R.J. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589:1992;291-301.
8. Beczkowska I.W., Koch J.E., Bodnar R.J. Naltrexone, serotonin receptor subtype antagonists and glucoprivic intake. I. 2-Deoxy-D-glucose Pharmacol. Biochem. Behav. 42:1992;661-669.
9. Beczkowska I.W., Koch J.E., Bostock M.E., Leibowitz S.F., Bodnar R.J. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 618:1993;261-270.
10. R.J. Bodnar, Opioid receptor subtype antagonists and ingestion. In: S.J. Cooper and P.J. Clifton (Eds.), Drug Receptor Subtypes and Ingestive Behaviour, Academic Press, London, 1996, pp. 127-146.
11. Bodnar R.J., Glass M.J., Ragnauth A., Cooper M.L. General, μ and κ opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700:1995;205-212.
12. Brown D.R., Holtzman S.G. Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol. Biochem. Behav. 11:1979;567-573.
13. Cador M., Kelley A.E., LeMoal M., Stinus L. Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience. 18:1986;659-669.
14. Cole J.L., Leventhal L., Pasternak G.W., Bowen W.D., Bodnar R.J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678:1995;168-176.
15. S.J. Cooper, A. Jackson, T.C. Kirkham, S. Turkish, Endorphins, opiates and food intake, in: R.J. Rodgers, S.J. Cooper (Eds.), Endorphins, Opiates and Behavioral Processes, John Wiley and Sons, New York, 1988, pp. 143-186.
16. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental μ, δ and κ opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1993;1236-1246.
17. Devine D.P., Leone P., Wise R.A. Mesolimbic dopamine neurotransmission is increased by administration of μ-opioid receptor antagonists. Eur. J. Pharmacol. 243:1993;55-64.
18. DiChara G., Imperato A. Opposite effects of μ and κ opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
19. Frenk H., Rogers G.H. The suppressant effects of naloxone on food and water intake in the rat. Behav. Neurol. Biol. 26:1979;23-40.
20. German D.C., Speciale S.G., Manaye K.F., Sadeq M. Opioid receptors in midbrain dopaminergic regions of the rat. I. μ Receptor autoradiography J. Neural Transm. 91:1993;39-52.
21. B.A. Gosnell, A.S. Levine, Stimulation of ingestive behaviour by preferential and selective opioid agonists, in: S.J. Cooper, P.G. Clifton (Eds.), Drug Receptor Subtypes and Ingestive Behaviour, Academic Press, London, 1996, pp. 147-166.
22. Gosnell B.A., Morley J.E., Levine A.S. Opioid-induced feeding: localization of sensitive brain sites. Brain Res. 369:1986;177-184.
23. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 277:1983;119-127.
24. Hamilton M.E., Bozarth M.A. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area. Life Sci. 43:1988;941-946.
25. Hawkins M.F., Cubic B., Baumeister A.A., Bartin C. Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats. Brain Res. 584:1992;261-265.
26. Hobbs D.J., Koch J.E., Bodnar R.J. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats. 1. Food deprivation Pharmacol. Biochem. Behav. 49:1994;197-204.
27. Islam A.K., Bodnar R.J. Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res. 508:1990;293-296.
28. Jackson H.C., Sewell R.D.E. Hyperphagia induced by 2-deoxy-D-glucose in the presence of the δ-opioid antagonist, ICI174864. Neuropharmacology. 24:1985;815-817.
29. Jenck F., Gratton A., Wise R.A. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Res. 423:1986;39-44.
30. 6]-enkephalin (DALCE) and naltrindole 5′-isothiocyanate (5′-NTII): evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
31. Joyce E.M., Iversen S.D. The effect of morphine applied locally to mesencephalic cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14:1979;207-212.
32. Kelley A.E., Bless E.P., Swanson C.J. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J. Pharmacol. Exp. Ther. 278:1996;1499-1507.
33. Kirkham T.C., Cooper S.J. Attenuation of sham feeding by naltrexone is stereospecific: evidence for opioid mediation of orosensory reward. Physiol. Behav. 43:1988;845-847.
34. Koch J.E., Bodnar R.J. Involvement of μ-1 and μ-2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 53:1993;603-605.
35. Koch J.E., Bodnar R.J. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res. 657:1994;191-201.
36. Koch J.E., Glass M.J., Cooper M.L., Bodnar R.J. Alterations in deprivation, glucoprivic and sucrose intake following general, μ and κ opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience. 66:1995;951-957.
37. Leone P., Pocock D., Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39:1991;469-472.
38. Leventhal L., Bodnar R.J. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Brain Res. 741:1996;300-308.
39. Levine A.S., Grace M., Billington C.J. β-funaltrexamine (B-FNA) decreases deprivation and opioid-induced feeding. Brain Res. 562:1991;281-284.
40. Levine A.S., Grace M., Billington C.J., Portoghese P.S. Nor-binaltorphamine decreases deprivation and opioid-induced feeding. Brain Res. 534:1990;60-64.
41. Levine A.S., Grace M., Welch W., Billington C.J., Portoghese P.S. Injection of opioid antagonists into the paraventricular nucleus: effects on deprivation-induced feeding. Soc. Neurosci. Abstr. 15:1989;896.
42. Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Bartness T.J. Opioids and consummatory behavior. Brain Res. Bull. 14:1985;663-672.
43. Lowy M.T., Maickel R.P., Yim G.K.W. Naloxone reduction of stress-related feeding. Life Sci. 26:1980;2113-2118.
44. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
45. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.T. Autoradiographic differentiation of μ, δ and κ opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
46. Marks-Kaufman R., Plager A., Kanarek R. Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats. Psychopharmacology. 85:1985;414-418.
47. Mattia A., Farmer S.C., Takemori A.E., Sultana M., Portoghese P.S., Mosberg H.I., Bowen W.D., Porreca F. Spinal opioid δ antinociception in the mouse: mediation by a 5′-NTII-sensitive δ receptor subtype. J. Pharmacol. Exp. Ther. 260:1992;518-525.
48. 2]-deltorphan II in mice: evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;583-587.
49. Mucha R.F., Iversen S.D. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 397:1986;214-224.
50. Nencini P., Stewart J. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50488H, microinjected into the ventral tegmental area in rats. Brain Res. 527:1990;254-258.
51. Noel M.B., Gratton A. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental μ receptor activation in freely behaving rats. Synapse. 21:1995;110-122.
52. Noel M.B., Wise R.A. Ventral tegmental injections of morphine but not U50488H enhance feeding in food-deprived rats. Brain Res. 632:1993;68-73.
53. Noel M.B., Wise R.A. Ventral tegmental injections of a selective μ or δ opioid enhance feeding in food-deprived rats. Brain Res. 673:1995;304-312.
54. Papadouka V., Carr K.D. The role of multiple opioid receptors in the maintainance of stimulation-induced feeding. Brain Res. 639:1994;42-48.
55. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1997.
56. Portoghese P.S., Larson D.L., Sayre L.M., Fries D.S., Takemori A.E. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23:1980;233-234.
57. Rockwood G.A., Reid L.D. Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29:1982;1175-1178.
58. Ruegg H., Yu W.-Z., Bodnar R.J. Opioid receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration. Physiol. Behav. IN PRESS. 000:1997;000-000.
59. Sawynok J., Pinsky C., LaBella F.S. On the specificity of naloxone as an opiate antagonist. Life Sci. 25:1979;1621-1632.
60. Schaefer L.A., Koch J.E., Bodnar R.J. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats. II. 2-Deoxy-D-glucose. Pharmacol. Biochem. Behav. 49:1994;205-211.
61. Segall M.A., Margules D.L. Central mediation of naloxone-induced anorexia in the ventral tegmental area. Behav. Neurosci. 103:1989;857-864.
62. Self D.W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94.
63. Siviy S.M., Reid L.D. Endorphinergic modulation of acceptability of putative reinforcers. Appetite. 4:1983;249-257.
64. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of δ opioid agonists by naltrindole and its benzofuran analogue (NTB) in mice: evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
65. Spanagel A., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vitro microdialysis study. J. Neurochem. 55:1990;1734-1740.
66. Speciale S.G., Manaye K.F., Sadeq M., German D.C. Opioid receptors in midbrain dopaminergic regions of the rat. II. κ and δ receptor autoradiography. J. Neural Transm. 91:1993;53-66.
67. Takemori A.E., Larson D.L., Portoghese P.S. The irreversible narcotic antagonist and reversible agonistic properties of the fumarate methyl ester derivative of naltrexone. Eur. J. Pharmacol. 70:1981;445-451.
68. Tempel A., Zukin R.S. Neuroanatomical patterns of μ, δ and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. (USA). 84:1987;4308-4312.
69. Ukai M., Holtzman S.G. Effects of beta-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153:1988;161-165.
70. Ward S.J., Portoghese P.S., Takemori A.E. Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J. Pharmacol. Exp. Ther. 220:1982;494-498.
71. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
72. Wise R.A., Hoffman D.C. Localization of drug reward mechanisms by intracranial injections. Synapse. 10:1992;247-263.
73. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
74. Woods J.S., Leibowitz S.F. Hypothalamic sites sensitive to morphine and naloxone: effects on feeding behavior. Pharmacol. Biochem. Behav. 23:1985;431-438.
75. Yim C.Y., Mogenson G.J. Electrophysiological studies of neurons in the ventral tegmental area of Tsai. Brain Res. 181:1980;301-313.
76. Yu W.-Z., Ruegg H., Bodnar R.J. δ and κ opioid receptor subtypes and ingestion: antagonist and glucoprivic effects. Pharmacol. Biochem. Behav. 56:1997;353-361.
77. Zukin R.S., Zukin S.R. Multiple opiate receptors: emerging concepts. Life Sci. 29:1981;2681-2690.